REYKJAVIK, Iceland, April 25 /PRNewswire-FirstCall/ -- deCODE genetics (Nasdaq: DCGN) today expressed its enthusiastic support for the Genetic Information Non-discrimination Act (GINA), a bill that, many years in the making, is now moving swiftly through Congress and is expected to be signed promptly by President Bush. GINA would provide a federal counterpart to existing legislation in many states prohibiting discrimination against individuals in matters of employment or healthcare coverage based upon the results of genetic tests or other genetic information.
deCODE was founded more than a decade ago with a simple mission: to discover the key genetic factors involved in major challenges to public health, and to turn these discoveries into better means of diagnosing, treating and preventing disease. In that time, deCODE has established itself as the world leader in discovering variations in the genome conferring risk of a range of common diseases, from diabetes to heart attack to common cancers. It has done so through the participation in its gene discovery programs by hundreds of thousands of people from around the world, and has in the process pioneered genotyping, data mining, and data and privacy protection methods for vast sets of genetic and healthcare information. Through its CLIA-registered reference laboratory the company now offers DNA-based risk assessment tests based upon its discoveries in a growing number of common diseases, as well as an informational personal genome analysis service through which individuals can put themselves in the context of advances in the field of human genetics.
"Legislation like GINA represents an important step forward in keeping
our ideas of civil rights and self determination up to d
|SOURCE deCODE genetics|
Copyright©2008 PR Newswire.
All rights reserved